scholarly journals Cerebrovascular and Cerebrometabolic Effects of Intracarotid Infused Platelet-Activating Factor in Rats

1988 ◽  
Vol 8 (4) ◽  
pp. 546-551 ◽  
Author(s):  
Patrick M. Kochanek ◽  
Edwin M. Nemoto ◽  
John A. Melick ◽  
Rhobert W. Evans ◽  
David F. Burke

Platelet-activating factor has been implicated in a variety of disease processes including ischemic brain injury and endotoxic shock, but its effects on cerebral blood flow (CBF) and metabolism in normal brain have not been described. The effects of platelet-activating factor on global CBF (hydrogen clearance) and the global cerebral metabolic rate for oxygen (CMRO2) were studied in halothane-N2O anesthetized Wistar rats. Hexadecyl-platelet-activating factor infused into the right carotid artery (67 pmol/min) for 60 min decreased mean arterial pressure (MAP) from 122 ±4 (x ± SEM) to 77 ± 6 mm Hg and CBF from 159 ± 12 to 116 ± 14 ml/100 g/min (p < 0.002). In contrast, CMRO2 increased from 9.7 ± 0.9 to 11.7 ± 1.1 ml/100 g/min after 15 min (p < 0.05). In controls rendered similarly hypotensive by blood withdrawal and infused with the platelet-activating factor vehicle, CMRO2 was unchanged, whereas CBF transiently decreased then returned to baseline at 60 min. These cerebrovascular and cerebrometabolic effects of PAF are reminiscent of and may be relevant to hypoperfusion and hypermetabolism observed after global brain ischemia and in endotoxic shock.

2020 ◽  
Vol 7 ◽  
pp. 184954352097081
Author(s):  
Rick Liao ◽  
Thomas R Wood ◽  
Elizabeth Nance

Excitotoxicity is a primary pathological process that occurs during stroke, traumatic brain injury (TBI), and global brain ischemia such as perinatal asphyxia. Excitotoxicity is triggered by an overabundance of excitatory neurotransmitters within the synapse, causing a detrimental cascade of excessive sodium and calcium influx, generation of reactive oxygen species, mitochondrial damage, and ultimately cell death. There are multiple potential points of intervention to combat excitotoxicity and downstream oxidative stress, yet there are currently no therapeutics clinically approved for this specific purpose. For a therapeutic to be effective against excitotoxicity, the therapeutic must accumulate at the disease site at the appropriate concentration at the right time. Nanotechnology can provide benefits for therapeutic delivery, including overcoming physiological obstacles such as the blood–brain barrier, protect cargo from degradation, and provide controlled release of a drug. This review evaluates the use of nano-based therapeutics to combat excitotoxicity in stroke, TBI, and hypoxia–ischemia with an emphasis on mitigating oxidative stress, and consideration of the path forward toward clinical translation.


Critical Care ◽  
2009 ◽  
Vol 13 (Suppl 1) ◽  
pp. P70
Author(s):  
Y Ko ◽  
B Allen ◽  
Z Tan ◽  
S Sakhai ◽  
G Buckberg

Physiology ◽  
2018 ◽  
Vol 33 (2) ◽  
pp. 99-112 ◽  
Author(s):  
Evelyn K. Shih ◽  
Michael B. Robinson

Until recently, astrocyte processes were thought to be too small to contain mitochondria. However, it is now clear that mitochondria are found throughout fine astrocyte processes and are mobile with neuronal activity resulting in positioning near synapses. In this review, we discuss evidence that astrocytic mitochondria confer selective resiliency to astrocytes during ischemic insults and the functional significance of these mitochondria for normal brain function.


2005 ◽  
Vol 25 (10) ◽  
pp. 1265-1279 ◽  
Author(s):  
Qiang Shen ◽  
Hongxia Ren ◽  
Haiying Cheng ◽  
Marc Fisher ◽  
Timothy Q Duong

Combined functional, perfusion and diffusion magnetic resonance imaging (MRI) with a temporal resolution of 30 mins was performed on permanent and transient focal ischemic brain injury in rats during the acute phase. The apparent diffusion coefficient (ADC), baseline cerebral blood flow (CBF), and functional MRI (fMRI) blood-oxygen-level-dependent (BOLD), CBF, and CMRO2 responses associated with CO2 challenge and forepaw stimulation were measured. An automated cluster analysis of ADC and CBF data was used to track the spatial and temporal progression of different tissue types (e.g., normal, ‘at risk,’ and ischemic core) on a pixel-by-pixel basis. With permanent ischemia ( n = 11), forepaw stimulation fMRI response in the primary somatosensory cortices was lost, although vascular coupling (CO2 response) was intact in some animals. Control experiments in which the right common carotid artery was ligated without causing a stroke ( n = 8) showed that the delayed transit time had negligible effect on the fMRI responses in the primary somatosensory cortices. With temporary (15-mins, n = 8) ischemia, transient CBF and/or ADC declines were observed after reperfusion. However, no T2 or TTC lesions were observed at 24 h except in two animals, which showed very small subcortical lesions. Vascular coupling and forepaw fMRI response also remained intact. Finally, comparison of the relative and absolute fMRI signal changes suggest caution when interpreting percent changes in disease states in which the baseline signals are physiologically altered; quantitative CBF fMRI are more appropriate measures. This approach provides valuable information regarding ischemic tissue viability, vascular coupling, and functional integrity associated with ischemic injury and could have potential clinical applications.


2005 ◽  
Vol 25 (1_suppl) ◽  
pp. S507-S507 ◽  
Author(s):  
Takashi Shichita ◽  
Hiroaki Ooboshi ◽  
Yasuhiro Kumai ◽  
Masahiro Kumai ◽  
Junichi Takada ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document